Today: 5. Nov, 2024
Investing in high-yield dividend stocks offers one of the most consistent ways to build wealth while ensuring a reliable source of passive income. By choosing stocks that provide solid dividends, investors can enjoy a steady income stream without constantly monitoring the market.…
The U.S. Food and Drug Administration (FDA) has given the green light to new Covid-19 vaccines from Pfizer and Moderna, paving the way for their widespread availability in the coming days. This approval arrives as the United States grapples with a summer…
In the dynamic realm of pharmaceutical investments, Pfizer and Viking Therapeutics have emerged as two contrasting options for investors. While Pfizer boasts stability and a generous dividend yield, Viking Therapeutics offers the allure of high growth potential with its innovative weight-loss candidate.…
Pfizer, a leading pharmaceutical company, made a significant announcement on Friday regarding developing its experimental weight loss pill. Despite the promising weight loss results in obese patients, the company decided to discontinue the twice-daily version of this pill due to tolerability issues…
U.S. stocks rebounded, unwinding some of the previous week’s downturn prompted by concerns over Middle East tensions. The leading indicators demonstrated resilience, with the S&P 500 surging 1% and the Nasdaq Composite jumping 1.2% during the morning session. This surge on Wall…
Moderna announced on Wednesday its combined COVID and flu vaccine will proceed to the ultimate trial phase for adults aged 50 and above this year, following promising outcomes from preliminary to mid-phase research. To secure regulatory approval by 2025, Moderna’s mRNA-1083 shot…
The latest wave of COVID-19 vaccinations in the U.S. has encountered some stumbling blocks, particularly around delayed health insurance coverage for the vaccines. Private insurers, along with government-funded programs like Medicare, are obligated to cover the costs of the newly released Pfizer…
